CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operations
Income (loss) from continuing operations		$ (957)	$ (638)	$ 2,663
Income (loss) from discontinued operations, net of tax		(57)	(312)	2,482
Income (loss) from continuing operations		(900)	(326)	181
Adjustments to reconcile net income (loss) to cash flows from operations:
Depreciation and amortization		981	997	984
Net periodic pension and other postretirement costs		(32)	(28)	(29)
Deferred income taxes		77	(262)	(256)
Stock compensation		117	114	115
Goodwill impairments		485	425	0
Indefinite-lived asset impairments		290	50	0
Other long-lived asset impairments		27	44	(11)
Gain on early extinguishment of debt		(16)	0	0
Other		30	41	62
Changes in balance sheet items:
Accounts receivable, net		(132)	(35)	(38)
Inventories		(119)	(201)	(128)
Prepaid expenses and other current assets		72	(125)	(45)
Accounts payable		3	112	92
Accrued expenses and other current liabilities		149	44	293
Other		(81)	(31)	(13)
Cash flows from (used in) operations – continuing operations		951	819	1,207
Cash flows from (used in) operations – discontinued operations		(106)	200	519
Cash flows from (used in) operations		845	1,019	1,726
Cash flows from investing activities
Capital expenditures		(513)	(446)	(432)
Acquisitions of developed technology and investments		(9)	(14)	(4)
Proceeds from sale of marketable equity securities		0	34	0
Other investing activities, net		58	16	26
Cash flows from (used in) investing activities - continuing operations		(464)	(410)	(410)
Cash flows from (used in) investing activities - discontinued operations		3,305	(216)	3,623
Cash flows from (used in) investing activities		2,841	(626)	3,213
Cash flows from financing activities
Issuances of debt		1,998	0	0
Increase in short term debt		0	1,830	0
Repayments of debt		(5,489)	(2,657)	(2,634)
Net (decreases) increases in debt with original maturities of three months or less		(300)	296	(301)
Cash dividends on common stock		(348)	(590)	(586)
Proceeds from stock issued under employee benefit plans		30	71	95
Payments of contingent liabilities		(50)	0	0
Other financing activities, net		(57)	(31)	(63)
Cash flows from (used in) financing activities		(4,216)	(1,081)	(3,489)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash		84	(96)	26
Increase (decrease) in cash, cash equivalents and restricted cash		(446)	(784)	1,476
Cash, cash equivalents and restricted cash at beginning of year	[1]	2,414	3,198	1,722
Cash, cash equivalents and restricted cash at end of year	[1]	1,968	2,414	3,198
Less cash and cash equivalents of discontinued operations		0	648	116
Cash, cash equivalents and restricted cash		$ 1,968	$ 1,766	$ 3,082

[1] The following table provides a reconciliation of cash, cash equivalents and restricted cash amounts as shown in the consolidated statement of cash flows to the amount reported in the consolidated balance sheet as of December 31, 2025, 2024, and 2023: As of December 31 (in millions)202520242023Cash and cash equivalents$1,966 $1,764 $3,078 Restricted cash included in prepaid expenses and other current assets2 2 4 Cash and cash equivalents of discontinued operations— 648 116 Cash, cash equivalents and restricted cash$1,968 $2,414 $3,198